Effects of the chemical chaperone 4-phenylbutylate on the function of the serotonin transporter (SERT) expressed in COS-7 cells

Journal of Pharmacological Sciences

Volumn 122, Issue 2, 2013, Pages 71-83

  Fujiwara, Masayuki ^a   Yamamoto, Hikaru ^a   Miyagi, Tatsuhiro ^a   Seki, Takahiro ^a   Tanaka, Shigeru ^a   Hide, Izumi ^a   Sakai, Norio ^a  

^a HIROSHIMA UNIVERSITY   (Japan)

Author keywords

Chemical chaperone; ER stress; Membrane trafficking; Serotonin transporter

Indexed keywords

4 PHENYLBUTYLATE; ADENOVIRUS VECTOR; BUTYLATE; BUTYRIC ACID; CHEMICAL CHAPERONE; DRUG; GLYCOSYLATED PROTEIN; SEROTONIN TRANSPORTER; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CELL MEMBRANE; CELL STRAIN COS7; CONCENTRATION RESPONSE; CONTROLLED STUDY; DELETION MUTANT; ENDOPLASMIC RETICULUM STRESS; FLUORESCENCE; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IMAGING; MEMBRANE TRANSPORT; NONHUMAN; PROTEIN EXPRESSION; PROTEIN FOLDING; PROTEIN FUNCTION; PROTEIN TRANSPORT; SEROTONINERGIC TRANSMISSION;

EID: 84880782224     PISSN: 13478613     EISSN: 13478648     Source Type: Journal    
DOI: 10.1254/jphs.12194FP     Document Type: Article

References (40)

1. Stahl SM. Essential Psychopharmacology: Neuroscientific Basis and Practical Applications. 2nd ed. Cambridge: Cambridge University Press; 2000.
2. Blakely RD, Berson HE, Fremeau RT Jr, Caron MG, Peek MM, Prince HK, et al. Cloning and expression of a functional serotonin transporter from rat brain. Nature. 1991;354:66-70.
3. Kuhar MJ, Roth RH, Aghajanian GK. Synaptosomes from forebrains of rats with midbrain raphe lesions: selective reduction of serotonin uptake. J Pharmacol Exp Ther. 1972;181: 36-45.
4. Han DD, Gu HH. Comparison of the monoamine transporters from human and mouse in their sensitivities to psychostimulant drugs. BMC Pharmacol. 2006;6:6.
5. Olivier B, Soudijn W, van Wijngaarden I. Serotonin, dopamine and norepinephrine transporters in the central nervous system and their inhibitors. Prog Drug Res. 2000;54:59-119.
6. Rudnick G, Wall SC. Binding of the cocaine analog 2 beta-[3H] carboxymethoxy-3 beta-(4-fluorophenyl)tropane to the serotonin transporter. Mol Pharmacol. 1991;40:421-426.
7. Caspi A, Sugden K, Moffitt TE, Taylor A, Craig IW, Harrington H, et al. Influence of life stress on depression: moderation by a polymorphism in the 5-HTT gene. Science. 2003;301:386-389.
8. Lesch KP, Bengel D, Heils A, Sabol SZ, Greenberg BD, Petri S, et al. Association of anxiety-related traits with a polymorphism in the serotonin transporter gene regulatory region. Science. 1996;274:1527-1531.
9. Ozaki N, Goldman D, Kaye WH, Plotnicov K, Greenberg BD, Lappalainen J, et al. Serotonin transporter missense mutation associated with a complex neuropsychiatric phenotype. Mol Psychiatry. 2003;8:933-936.
10. Prasad HC, Steiner JA, Sutcliffe JS, Blakely RD. Enhanced activity of human serotonin transporter variants associated with autism. Philos Trans R Soc Lond B Biol Sci. 2009;364:163-173.
11. Sutcliffe JS, Delahanty RJ, Prasad HC, McCauley JL, Han Q, Jiang L, et al. Allelic heterogeneity at the serotonin transporter locus (SLC6A4) confers susceptibility to autism and rigid-compulsive behaviors. Am J Hum Genet. 2005;77:265-279.
12. Tate CG, Blakely RD. The effect of N-linked glycosylation on activity of the Na(+)- and Cl(-)-dependent serotonin transporter expressed using recombinant baculovirus in insect cells. J Biol Chem. 1994;269:26303-26310.
13. Samuvel DJ, Jayanthi LD, Bhat NR, Ramamoorthy S. A role for p38 mitogen-activated protein kinase in the regulation of the serotonin transporter: evidence for distinct cellular mechanisms involved in transporter surface expression. J Neurosci. 2005;25: 29-41.
14. Zhu CB, Carneiro AM, Dostmann WR, Hewlett WA, Blakely RD. p38 MAPK activation elevates serotonin transport activity via a trafficking-independent, protein phosphatase 2A-dependent process. J Biol Chem. 2005;280:15649-15658.
15. Zhu CB, Hewlett WA, Feoktistov I, Biaggioni I, Blakely RD. Adenosine receptor, protein kinase G, and p38 mitogen-activated protein kinase-dependent up-regulation of serotonin transporters involves both transporter trafficking and activation. Mol Pharmacol. 2004;65:1462-1474.
16. El-Kasaby A, Just H, Malle E, Stolt-Bergner PC, Sitte HH, Freissmuth M, et al. Mutations in the carboxyl-terminal SEC24 binding motif of the serotonin transporter impair folding of the transporter. J Biol Chem. 2010;285:39201- 39210.
17. Larsen MB, Fjorback AW, Wiborg O. The C-terminus is critical for the functional expression of the human serotonin transporter. Biochemistry. 2006;45:1331-1337.
18. Nobukuni M, Mochizuki H, Okada S, Kameyama N, Tanaka A, Yamamoto H, et al. The C-terminal region of serotonin transporter is important for its trafficking and glycosylation. J Pharmacol Sci. 2009;111:392-404.
19. Bossy-Wetzel E, Schwarzenbacher R, Lipton SA. Molecular pathways to neuro degeneration. Nat Med. 2004;10 Suppl:S2-S9.
20. Paschen W, Mengesdorf T. Cellular abnormalities linked to endoplasmic reticulum dysfunction in cerebrovascular disease\- therapeutic potential. Pharmacol Ther. 2005;108:362-375.
21. Paschen W, Mengesdorf T. Endoplasmic reticulum stress response and neurodegeneration. Cell Calcium. 2005;38:409-415.
22. Ozcan U, Yilmaz E, Ozcan L, Furuhashi M, Vaillancourt E, Smith RO, et al. Chemical chaperones reduce ER stress and restore glucose homeostasis in a mouse model of type 2 diabetes. Science. 2006;313:1137-1140.
23. Powell K, Zeitlin PL. Therapeutic approaches to repair defects in deltaF508 CFTR folding and cellular targeting. Adv Drug Deliv Rev. 2002;54:1395-1408.
24. Tamarappoo BK, Verkman AS. Defective aquaporin-2 trafficking in nephrogenic diabetes insipidus and correction by chemical chaperones. J Clin Invest. 1998;101:2257-2267.
25. Burrows JA, Willis LK, Perlmutter DH. Chemical chaperones mediate increased secretion of mutant alpha 1-antitrypsin (alpha 1-AT) Z: A potential pharmacological strategy for prevention of liver injury and emphysema in alpha 1-AT deficiency. Proc Natl Acad Sci U S A. 2000;97:1796-1801.
26. Kubota K, Niinuma Y, Kaneko M, Okuma Y, Sugai M, Omura T, et al. Suppressive effects of 4-phenylbutyrate on the aggregation of Pael receptors and endoplasmic reticulum stress. J Neurochem. 2006;97:1259-1268.
27. Rubenstein RC, Zeitlin PL. Sodium 4-phenylbutyrate down-regulates Hsc70: implications for intracellular trafficking of DeltaF508-CFTR. Am J Physiol Cell Physiol. 2000;278: C259-C267.
28. Wei H, Kim SJ, Zhang Z, Tsai PC, Wisniewski KE, Mukherjee AB. ER and oxidative stresses are common mediators of apoptosis in both neurodegenerative and non-neurodegenerative lysosomal storage disorders and are alleviated by chemical chaperones. Hum Mol Genet. 2008;17:469-477.
29. Crowe JH. Trehalose as a "chemical chaperone": fact and fantasy. Adv Exp Med Biol. 2007;594:143-158.
30. Qi X, Hosoi T, Okuma Y, Kaneko M, Nomura Y. Sodium 4-phenylbutyrate protects against cerebral ischemic injury. Mol Pharmacol. 2004;66:899-908.
31. Mochizuki H, Amano T, Seki T, Matsubayashi H, Mitsuhata C, Morita K, et al. Role of C-terminal region in the functional regulation of rat serotonin transporter (SERT). Neurochem Int. 2005;46:93-105.
32. Seki T, Shimahara T, Yamamoto K, Abe N, Amano T, Adachi N, et al. Mutant gammaPKC found in spinocerebellar ataxia type 14 induces aggregate-independent maldevelopment of dendrites in primary cultured Purkinje cells. Neurobiol Dis. 2009;33:260-273.
33. Yamamoto K, Seki T, Adachi N, Takahashi T, Tanaka S, Hide I, et al. Mutant protein kinase C gamma that causes spinocerebellar ataxia type 14 (SCA14) is selectively degraded by autophagy. Genes Cells. 2010;15:425-438.
34. Sakai N, Sasaki K, Nakashita M, Honda S, Ikegaki N, Saito N. Modulation of serotonin transporter activity by a PKC activator and an inhibitor of type 1 and 2A serine/threonine phosphatases. J Neurochem. 1997;68:2618-2624.
35. Seki T, Adachi N, Ono Y, Mochizuki H, Hiramoto K, Amano T, et al. Mutant protein kinase Cgamma found in spinocerebellar ataxia type 14 is susceptible to aggregation and causes cell death. J Biol Chem. 2005;280:29096-29106.
36. Yammamoto H, Tanaka S, Tanaka A, Hide I, Seki T, Sakai N. Long-Term Exposure of RN46A Cells expressing serotonin transporter (SERT) to a cAMP analog up-regulates SERT activity and is accompanied by neural differentiation of the cells. J Pharmacol Sci. 2013;121:25-38.
37. Yamamoto H, Fujimiya M, Shirai Y, Nakashita M, Oyasu M, Saito N. Immunohistochemical localization of serotonin transporter in normal and colchicine treated rat brain. Neurosci Res. 1998;32:305-312.
38. Kang HL, Benzer S, Min KT. Life extension in Drosophila by feeding a drug. Proc Natl Acad Sci U S A. 2002;99:838-843.
39. Wright JM, Zeitlin PL, Cebotaru L, Guggino SE, Guggino WB. Gene expression profile analysis of 4-phenylbutyrate treatment of IB3-1 bronchial epithelial cell line demonstrates a major influence on heat-shock proteins. Physiol Genomics. 2004;16: 204-211.
40. Mori K. Tripartite management of unfolded proteins in the endo-plasmic reticulum. Cell. 2000;101:451-454.